Evidence map›Paper›PMID 21990968›Full record

ArticlePLoS computational biology2011

Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo?

Marjet Elemans, Nafisa-Katrin Seich Al Basatena, Nichole R Klatt, Christos Gkekas, Guido Silvestri, Becca Asquith

Abstract read
In one paragraph

Article in PLoS computational biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. CD8Nature communications · 2023
    Article
  5. Article
  6. Towards multiscale modeling of the CD8Wiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Modeling T cell responses to antigenic challenge.Journal of pharmacokinetics and pharmacodynamics · 2014
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marjet ElemansDepartment of Immunology, Imperial College London, London, United Kingdom. m.elemans@imperial.ac.uk
Nafisa-Katrin Seich Al Basatena
Nichole R Klatt
Christos Gkekas
Guido Silvestri
Becca Asquith

Funding

Medical Research Council G0601072Medical Research Council G0601072-79700Wellcome Trust
6 · The paper itself

Abstract

In January 2010 two groups independently published the observation that the depletion of CD8+ cells in SIV-infected macaques had no detectable impact on the lifespan of productively infected cells. This unexpected observation led the authors to suggest that CD8+ T cells control SIV viraemia via non-lytic mechanisms. However, a number of alternative plausible explanations, compatible with a lytic model of CD8+ T cell control, were proposed. This left the field with no consensus on how to interpret these experiments and no clear indication whether CD8+ T cells operated primarily via a lytic or a non-lytic mechanism. The aim of this work was to investigate why CD8+ T cells do not appear to reduce the lifespan of SIV-infected cells in vivo.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell SurvivalComputational BiologyLymphocyte DepletionMacacaModels, TheoreticalSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadViremia

Identifiers

PMID21990968
PMCPMC3182865

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.